InvestorsHub Logo
Followers 277
Posts 13764
Boards Moderated 0
Alias Born 02/17/2014

Re: None

Sunday, 02/12/2017 8:03:21 PM

Sunday, February 12, 2017 8:03:21 PM

Post# of 82
On Feb 6th, 2017 Biotron (BITRF) released phenomenal results from it's latest study that showed it's lead pipeline drug BIT225 significantly reduces HIV-1 viral loads from the system beyond the current best anti-retroviral treatments for HIV-1. Meaning BIT225 is more EFFECTIVE than any approved drug treatment that's available today but even more significant it helped not only cure but ERADICATE HIV-1 from the system!